Clinical Trials Logo

Filter by:
NCT ID: NCT02084888 Completed - Clinical trials for Coronary Artery Disease

Prognostic Impact of Chronic Total Occlusions

Start date: January 2005
Phase: N/A
Study type: Observational [Patient Registry]

The purpose of this study is to determine the prognostic impact of the presence of chronic total occlusions (CTO) of the coronary arteries in patients undergoing coronary angiography and PCI.

NCT ID: NCT02083991 Completed - Diabetes Mellitus Clinical Trials

Trial of Steroid Avoidance and Low-dose CNI by ATG-induction in Renal Transplantation

SAILOR
Start date: January 2013
Phase: Phase 4
Study type: Interventional

Balancing immunosuppressive treatment in organ transplantation in order to achieve effective prevention of rejection on one side and avoidance of negative side effects on the other side is a major challenge, leading to developing different immunosuppressive protocols. Cornerstones of immunosuppressive treatment such as Corticosteroids (CS) and Calcineurin Inhibitors (CNI) are known to cause an increased incidence of diabetes, cardiovascular morbidity, nephrotoxicity and malignancies. The investigators believe that both avoidance of CS and minimization of CNI, while using Anti-ThymocyteGlobuline(ATG) induction (instead of interleucin-2 receptor blockers) and mycofenolate mofetil(MMF) therapeutic drug monitoring is going to reduce negative side effects, without increased rejection frequency in renal transplanted patients.

NCT ID: NCT02083263 Completed - Cystic Fibrosis Clinical Trials

Non Invasive Ventilation as Airway Clearance in Patients With Cystic Fibrosis

Start date: October 2012
Phase: N/A
Study type: Interventional

With the use of Non invasive ventilation the patients with cystic fibrosis will have better lung function (FEV1).

NCT ID: NCT02082613 Recruiting - Clinical trials for Testicular Hydrocele

Lord´s Procedure Versus Sclerotherapy for Testicular Hydrocele; a Randomized Controlled Study

Start date: February 2015
Phase: N/A
Study type: Interventional

This study will compare a minimal invasive operation in local anesthesia with sclerotherapy for symptomatic testicular hydrocele within 6 months after randomization. Thirty days complication rates will be assessed. The hypothesis is that surgery will lead to faster cure while sclerotherapy would be cheaper and have less complications.

NCT ID: NCT02081547 Recruiting - Rectal Cancer Clinical Trials

IPC Status as a Surgical Quality Marker in Rectal Cancer Surgery

Start date: April 2012
Phase: N/A
Study type: Observational

Risk of local recurrence after rectal surgery is nationally 8% after curative surgery to 5%. Local recurrence rate after curative surgery varies between 3-7% in the variety of regions in the country. It is well known that the surgical technique total mesorectal excision (TME) has led to improved prognosis after rectal cancer surgery. TME surgery is difficult to perform and different factors affect the quality of TME preparations. Injuries in mesorectal fascia has been reported in up to 20% of patients who underwent TME surgery and most surgeons agree that this may be important for recurrences. However, it is unclear to what extent a damaged mesorectal fascia can be related to a worsening of prognosis in patients with rectal cancer. Adjuvant oncological treatment in form of chemotherapy after surgery, is offers patients with unfavorable tumors based on the pathological examination. Patients with favorable tumors (less advanced) are not offered chemotherapy, even if the surgical technique was not optimal, ie. that there is damage in the mesorectal fascia, as evidence for this is lacking. The presence of intraperitoneal cancer cells (IPC) is related to histopathological tumor stage of colorectal cancer. Incidence of IPC of intraperitoneal tumors (rectal cancer patients with tumors below the peritoneal reflection) is unclear. Assessment of IPC status with cytology and immunohistochemistry is technically easy and could after TME surgery identify those patients who have an increased risk of tumor recurrence. In a positive IPC status, the patient would possibly benefit from either postoperative radiotherapy if the patient did not receive preoperative therapy, or postoperative oncological chemotherapy. Tumour cells may be lysed in sterile water, and some surgeons rinse the abdominal cavity and the bowel distally to the tumour. Neither rinsing the abdomen or rectum in colorectal cancer is routinely occurring and the clinical benefit has not been established. The value of rinsing the abdomen after TME-surgery could also be studied by IPC status. The study hypothesis is that the IPC status is dependent on the surgical quality of the specimen after TME-surgery in rectal cancer patients, and its presence leads to increased risk of local recurrence.

NCT ID: NCT02079298 Completed - Clinical trials for Bacterial Infections and Mycoses

Safety of Fluconazole Treatment of Premature and Full-term Newborn Infants

Start date: April 2014
Phase: Phase 4
Study type: Interventional

This study will investigate pharmacological interventions between fluconazole and ibuprofen when they are given to premature newborn babys. This in order to find out if the drugs are influencing each other when they are given at the same time. The study is meant to find out if there are reasons to adjust the dose when fluconazole and ibuprofen are given together.

NCT ID: NCT02078856 Completed - Clinical trials for Bile Acid Malabsorption

Double-blind, Randomised Study of A3384 in BAM/BAD

Start date: March 2014
Phase: Phase 2
Study type: Interventional

The purpose of this trial is to determine the efficacy and safety of A3384 administered to patients with Bile Acid Malabsorption (BAM)/Bile Acid Diarrhoea (BAD).

NCT ID: NCT02078427 Completed - Hemophilia A Clinical Trials

ADVATE/ ADYNOVI Hemophilia A Outcome Database (AHEAD)

AHEAD
Start date: June 28, 2011
Phase:
Study type: Observational

The purpose of the study is to document the natural history of hemophilia A disease and long-term outcomes in terms of effectiveness, safety and quality of life in participants receiving Antihemophilic Factor (Recombinant) - Plasma/Albumin Free Method (rAHF-PFM) or Antihemophilic Factor (Recombinant) - Pegylated (rAHF-PEG) in routine clinical practice

NCT ID: NCT02078414 Completed - Contraception Clinical Trials

Continued Use of Effective Contraception After Use of Emergency Contraception

Start date: March 2014
Phase:
Study type: Observational

Women using an emergency contraceptive method must use back up protection for 1-2 weeks depending on method. The Copper-IUD is the most effective emergency contraceptive method. The investigators wish to explore if women choosing the Cooper IUD have a higher frequency of use of an effective contraceptive method 3 months and 6 months after the use of an emergency contraceptive method than women who choose to use the emergency contraceptive pill EllaOne (ulipristal acetate).

NCT ID: NCT02078245 Recruiting - Clinical trials for Hereditary Pancreatitis

Quality Control Study of MR Based Screening of Individual With Increased Risk for Pancreas Cancer.

Start date: August 2010
Phase:
Study type: Observational [Patient Registry]

Early detection of pre-cancerous lesions or early stage pancreatic cancer seems to have a positive impact in survival for patients with an increased genetic risk to develop pancreas cancer. In this study, following the indication of the swedish guidelines, consecutive patients with a family history for pancreas cancer underwent a clinical surveillance Magnetic Resonance Imaging (MRI) based. The results of this study were analyzed looking in the patients files collected during the screening period.